89 related articles for article (PubMed ID: 7786583)
1. Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2.
Abimiku AG; Franchini G; Aldrich K; Myagkikh M; Markham P; Gard E; Gallo RC; Robert-Guroff M
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):383-93. PubMed ID: 7786583
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
Venet A; Bourgault I; Aubertin AM; Kiény MP; Levy JP
J Immunol; 1992 May; 148(9):2899-908. PubMed ID: 1349322
[TBL] [Abstract][Full Text] [Related]
3. Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.
Legrand E; Pellegrin I; Neau D; Pellegrin JL; Ragnaud JM; Dupon M; Guillemain B; Fleury HJ
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1383-94. PubMed ID: 9359658
[TBL] [Abstract][Full Text] [Related]
4. Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects.
Franchini G; Markham P; Gard E; Fargnoli K; Keubaruwa S; Jagodzinski L; Robert-Guroff M; Lusso P; Ford G; Wong-Staal F
J Virol; 1990 Sep; 64(9):4462-7. PubMed ID: 2117071
[TBL] [Abstract][Full Text] [Related]
5. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
6. Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.
Myagkikh M; Alipanah S; Markham PD; Tartaglia J; Paoletti E; Gallo RC; Franchini G; Robert-Guroff M
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):985-92. PubMed ID: 8827214
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants.
Rud EW; Cranage M; Yon J; Quirk J; Ogilvie L; Cook N; Webster S; Dennis M; Clarke BE
J Gen Virol; 1994 Mar; 75 ( Pt 3)():529-43. PubMed ID: 8126450
[TBL] [Abstract][Full Text] [Related]
9. Virus-specific cytotoxic T-lymphocytes in HIV-2-infected cynomolgus macaques.
Voss G; Nick S; Otteken A; Lüke W; Stahl-Hennig C; Hunsmann G
AIDS; 1992 Oct; 6(10):1077-83. PubMed ID: 1466839
[TBL] [Abstract][Full Text] [Related]
10. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
Liu ZQ; Muhkerjee S; Sahni M; McCormick-Davis C; Leung K; Li Z; Gattone VH; Tian C; Doms RW; Hoffman TL; Raghavan R; Narayan O; Stephens EB
Virology; 1999 Aug; 260(2):295-307. PubMed ID: 10417264
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization of rhesus macaques against SIV infection and disease.
Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
[TBL] [Abstract][Full Text] [Related]
12. Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: a proof of concept study in macaques.
Koopman G; Beenhakker N; Hofman S; Walther-Jallow L; Mäkitalo B; Mooij P; Anderson J; Verschoor E; Bogers WM; Heeney JL; Spetz AL
Vaccine; 2012 Mar; 30(15):2523-34. PubMed ID: 22314133
[TBL] [Abstract][Full Text] [Related]
13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
16. Induction of long-term protective effects against heterologous challenge in SIVhu-infected macaques.
Villinger F; Switzer WM; Parekh BS; Otten RA; Adams D; Shanmugam V; Bostik P; Mayne AE; Chikkala NF; McClure HM; Novembre F; Yao Q; Heneine W; Folks TM; Ansari AA
Virology; 2000 Dec; 278(1):194-206. PubMed ID: 11112494
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
18. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.
Singh DK; McCormick C; Pacyniak E; Lawrence K; Dalton SB; Pinson DM; Sun F; Berman NE; Calvert M; Gunderson RS; Wong SW; Stephens EB
Virology; 2001 Mar; 282(1):123-40. PubMed ID: 11259196
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation.
Singh DK; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Berman NE; Stephens EB
Virology; 2002 Apr; 296(1):39-51. PubMed ID: 12036316
[TBL] [Abstract][Full Text] [Related]
20. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.
Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS
Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]